ESC 365 - Virus-mediated gene transfer to induce cardiac repair: where do we stand?

CBS PREMIUM ACCESS

Virus-mediated gene transfer to induce cardiac repair: where do we stand?

Session: Targeted delivery of therapeutic agents to the heart - challenges and perspectives

Topic: Drugs, Drug Targets

Speaker: Doctor M. Gladka (Amsterdam, NL)

Event: Frontiers in CardioVascular Biomedicine 2024

Congress Presentation

Add to my library

About the speaker

Doctor Monika Gladka

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

2 presentations

0 follower

3 more presentations in this session

Extracellular vesicle subtypes for therapeutic application: challenges to overcome

Speaker: Professor J. Sluijter (Utrecht, NL)

Utilisation and potential of RNA-based therapies in cardiovascular disease

Speaker: Doctor S. Ounzain (Lausanne, CH)

Dissecting signal transduction pathways that regulate cardiomyocyte proliferation

Speaker: Miss R. Artioli (Trieste, IT)

Access the full session

Targeted delivery of therapeutic agents to the heart - challenges and perspectives

Speakers: Doctor M. Gladka, Professor J. Sluijter, Doctor S. Ounzain, Miss R. Artioli

About the event

Frontiers in CardioVascular Biomedicine 2024

12 April - 14 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources